Tweet
Can Commun Dis Rep. 2019 Jan 3;45(1):38-43. doi: 10.14745/ccdr.v45i01a05. eCollection 2019 Jan 3.
Canadian Pandemic Influenza Preparedness: Antiviral strategy.
Henry B1,2.
Author information
Abstract
Antiviral medications are the only influenza-specific pharmaceutical intervention that can be used to mitigate the impact of a pandemic until a vaccine becomes available. The Canadian Pandemic Influenza Preparedness: Planning Guidance for the Health Sector (CPIP) outlines how federal, provincial and territorial governments will work together to ensure a coordinated and consistent health sector approach to pandemic influenza preparedness and response. This article summarizes Canada's pandemic influenza antiviral strategy as described in the recently updated CPIP Antiviral Annex. The antiviral strategy builds on lessons learned during the 2009 H1N1 pandemic. Key elements of the strategy include ensuring equitable, timely and coordinated access to antivirals through government stockpiles; having regulatory mechanisms in place that facilitate timely access to antivirals; providing timely and evidence-based clinical guidance; maintaining effective stockpile management practices; and monitoring antiviral utilization, effectiveness and safety. Since the CPIP is an evergreen document, this Annex will be updated as new information warrants.
KEYWORDS:
antivirals; influenza; pandemic; public health
PMID: 31015817 PMCID: PMC6461127 DOI: 10.14745/ccdr.v45i01a05
Free PMC Article
Text-to-speech function is limited to 200 characters
Canadian Pandemic Influenza Preparedness: Antiviral strategy.
Henry B1,2.
Author information
Abstract
Antiviral medications are the only influenza-specific pharmaceutical intervention that can be used to mitigate the impact of a pandemic until a vaccine becomes available. The Canadian Pandemic Influenza Preparedness: Planning Guidance for the Health Sector (CPIP) outlines how federal, provincial and territorial governments will work together to ensure a coordinated and consistent health sector approach to pandemic influenza preparedness and response. This article summarizes Canada's pandemic influenza antiviral strategy as described in the recently updated CPIP Antiviral Annex. The antiviral strategy builds on lessons learned during the 2009 H1N1 pandemic. Key elements of the strategy include ensuring equitable, timely and coordinated access to antivirals through government stockpiles; having regulatory mechanisms in place that facilitate timely access to antivirals; providing timely and evidence-based clinical guidance; maintaining effective stockpile management practices; and monitoring antiviral utilization, effectiveness and safety. Since the CPIP is an evergreen document, this Annex will be updated as new information warrants.
KEYWORDS:
antivirals; influenza; pandemic; public health
PMID: 31015817 PMCID: PMC6461127 DOI: 10.14745/ccdr.v45i01a05
Free PMC Article
| Detect languageundefined | undefined |
Text-to-speech function is limited to 200 characters